DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA455983
Title:
An Oral DNA Vaccine Encoding Endoglin Eradicates Breast Tumors by Blocking Their Blood Supply
Descriptive Note:
Annual rept. 12 Apr 2005-11 Apr 2006
Corporate Author:
SCRIPPS RESEARCH INST LA JOLLA CA
Report Date:
2006-05-01
Pagination or Media Count:
35.0
Abstract:
We extended our research efforts on the endoglin-based DNA vaccine for the treatment of breast cancer. We attained our goals for the second fiscal year, first, by constructing unique expression plasmids encoding endoglin and co-expressing IL-15 or encoding IL-7, the latter to be co-expressed with endoglin. Second, we verified the correct protein expression of those plasmids by Western blotting, assessed anti-angiogenic effects by imaging and Matrigel assays and optimized antigen processing and presentation. Third, we critically evaluated anti-angiogenic and anti-tumor efficacies of the DNA vaccines in vivo in orthotopic as well as spontaneous and experimental D2F2 mouse breast tumor metastasis models in syngeneic BALBc mice.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE
